Skip to main content
. 2021 Jun 15;12(6):706–729. doi: 10.4239/wjd.v12.i6.706

Figure 5.

Figure 5

Strategies for treating type 2 diabetes mellitus and concurrent osteoporosis. CKD-MBD: Chronic kidney disease–mineral and bone disorder; DPP-4i: Dipeptidyl-peptidase 4 inhibitor; GLP-1: Glucagon-like peptide-1; T2DM: Type 2 diabetes mellitus.